Capromorelin Tartrate
1,542 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,542
Total Reports
223
Deaths Reported
1450.0%
Death Rate
Active Ingredients
Capromorelin Tartrate
Administration Routes
OralUnknownIntravenousTransdermalCutaneousIntraocularTopicalOphthalmicOther
Species Affected
Dog 769
Cat 476
Unknown 277
Human 17
Ferret 1
Primate 1
Mouse 1
Most Affected Breeds
Unknown 295
Domestic Shorthair 189
Dog (unknown) 146
Cat (unknown) 137
Retriever - Labrador 46
Chihuahua 37
Domestic Longhair 36
Shih Tzu 34
Domestic Mediumhair 33
Crossbred Canine/dog 28
Most Reported Reactions
Lack of efficacy - NOS 258
Vomiting 181
Death by euthanasia 124
Lethargy (see also Central nervous system depression in 'Neurological') 117
UNPALATABLE 117
Hypersalivation 105
Behavioural disorder NOS 99
Death 96
Lethargy (see also Central nervous system depression in Neurological) 94
Diarrhoea 83
Not eating 83
Drooling 68
Outcome Breakdown
Outcome Unknown
509 (40.1%)
Recovered/Normal
269 (21.2%)
Ongoing
267 (21.1%)
Euthanized
123 (9.7%)
Died
100 (7.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.